As Dr.
reported in this Substack, ridiculous notions of counterfactuals are being made by credentialed scientists — such as the absurdity that COVID treatment and prevention protocols have “saved” 3 million lives.It’s funny how a disease which, on its worst day, was never more than twice as bad as a severe flu, could have caused millions of deaths in the counterfactual. How can you ever get millions of deaths from a disease with an IFR of less than 0.28%?
[crickets]
At an IFR of 0.25%, which is still higher than the most likely original IFR, then 400 people need to be infected for each COVID death. If you need 3 million deaths to occur — because you created some crazy counterfactual which requires it — then that requires a minimum of 1.2 billion COVID infections.
Spoiler: The USA doesn’t have 1.2 billion people
Obviously they are using a higher IFR than what is compatible with known death data, but why let them have all the fun creating counter-factuals out of thin air with completely unsupported and unjustifiable assumptions which outright deny reality?
To take it down a notch, I found a study involving Dr. Peter McCullough and other researchers on a treatment protocol for COVID which is likely to reduce mortality by over 75%.
In the counterfactual situation where government officials allowed good news to spread about treatments which work, there’d be much less death than we’ve seen.
While only 24 people took the 10-day protocol — which I will refer to as the ZIDDC Protocol ("Zinc, Ivermectin, Doxycycline, Vitamin D, Vitamin C") — most were in really bad shape with hypoxia and most were older and with comorbidities, yet none required hospitalization, and none died.
There was 100% survival even though the average from the CDC “COVID patient database” would have predicted much less survival. The researchers performed a statistical test on their findings, but I think a better statistical test might have led to even better results.
Here are the notes I took about the study:
[click image to enlarge]
At bottom, you can see the test they ran, using the results of over 300,000 matched COVID patients out of the CDC database to get an expected count of deaths in their sample. But I ran 3 other tests on the data at the top of the sheet, and found even more significance.
If the death rate of the 300,000-plus matched controls were applied to the sample, there’d be little chance of getting no deaths. The tests I used are “solid” ones, but the test that the researchers used involved an assumption about meeting minimum expected counts.
Now that the superiority of the ZIDDC Protocol over usual care (CDC patient data involves patients who got a standard of care) has been strengthened by further analysis, let’s envision what the weekly death would have looked like versus our “conventional-treatment baseline.”
Though there was a 100% reduction in COVID mortality on the ZIDDC Protocol, a Poisson Confidence Interval indicates that we can only be very confident in approximately a 57% reduction, while a 75% reduction in death is even more likely, especially with a modified* ZIDDC Protocol:
And here is the same image with notes at the peaks, showing how many American lives would have been saved in just those 4 weeks over this two-year ordeal:
There are 107 weeks showing here, from 1 Mar 2020 to 13 Mar 2022, and if the ZIDDC Protocol had been widely adopted from the beginning, literally hundreds of thousands of American lives would have been spared — not just the 70,000 American lives saved in those 4 highlighted weeks.
==============
*The modified protocol would double the zinc, double the vitamin C, and triple the vitamin D which was used in a 10-day protocol to save all 24 of the 24 patients from any serious harm — even though they had high risk of harm initially.
I suspect that the dose of ivermectin could have been higher, but I will leave opinions on that topic to experts such as Dr.
.==============
Reference
[study which took people who were in really bad shape, and saved them all without even a single hospitalization] — Hazan S, Dave S, Gunaratne AW, Dolai S, Clancy RL, McCullough PA, Borody TJ. Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients. Future Microbiol. 2022 Mar;17:339-350. doi: 10.2217/fmb-2022-0014. Epub 2022 Feb 9. Erratum in: Future Microbiol. 2022 Sep;17:1091. PMID: 35135310; PMCID: PMC8826831. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826831/